Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001171843-16-012293
Filing Date
2016-09-27
Accepted
2016-09-27 19:02:12
Documents
2
Period of Report
2016-09-27

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3_svoronos092716.html 3  
1 OWNERSHIP DOCUMENT f3_svoronos092716.xml 3 3477
2 POWER OF ATTORNEY exh_241.htm EX-24.1 5507
  Complete submission text file 0001171843-16-012293.txt   10441
Mailing Address C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105
Business Address
Svoronos Dawn (Reporting) CIK: 0001574579 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36687 | Film No.: 161905486

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations